0 likes | 2 Vues
The Leuprolide Acetate Market was valued at USD 2.8 billion in 2024 and is expected to reach approximately USD 4.9 billion by 2034, registering a compound annual growth rate (CAGR) of 6% over the 2025u20132034 forecast period. Market growth is primarily fueled by the rising incidence of hormone-sensitive cancers, increasing awareness of reproductive health disorders, and the growing adoption of hormone therapies across diverse clinical applications.
E N D